OpenAI acquires Orchestra Bio for drug-development AI agents
Orchestra will fold into Rosalind; terms were not disclosed, and OpenAI already works with Novo Nordisk and Moderna.
46
Orchestra will fold into Rosalind; terms were not disclosed, and OpenAI already works with Novo Nordisk and Moderna.
Terms were undisclosed; the four-year-old startup had reportedly raised about $20 million by 2025.
Orchestra’s drug-program agents will join GPT-Rosalind and Rosalind Workbench to coordinate studies and timelines.
Boston Scientific disclosed a cyberattack that caused a network outage, disrupting global operations including order processing and shipping.
Entities are extracted by the model from each article. First seen , last mentioned . Watching keeps it in this browser only (no account); the watchlist page and dashboard alerts use it.
Today 1.6K readers · 3.2K views · 2.4K reads · all time 161K views